(Q35581362)

9 August 2017

1 reference

title

PET scan in the staging of non-small cell lung cancer (English)

1 reference

9 August 2017

author name string

Johan F. Vansteenkiste

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14611912

31 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14611912

31 March 2024

publication date

1 December 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S0169500203003027?httpAccept=text/xml

1 reference

10.1016/S0169-5002(03)00302-7

DOI

https://api.crossref.org/works/10.1016/S0169-5002(03)00302-7

https://api.elsevier.com/content/article/PII:S0169500203003027?httpAccept=text/plain

31 March 2024

1 reference

10.1016/S0169-5002(03)00302-7

DOI

https://api.crossref.org/works/10.1016/S0169-5002(03)00302-7

31 March 2024

1 reference

9 August 2017

volume

42 Suppl 1

1 reference

9 August 2017

page(s)

S27-37

1 reference

The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Evaluation of the effect of thrombolytic treatment on infarct size and left ventricular function by enzymatic, scintigraphic, and angiographic methods. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Glucose utilization in vivo by human pulmonary neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

FDG PET of pleural effusions in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Evaluation of the solitary pulmonary nodule by positron emission tomography imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Distribution of distant metastases from newly diagnosed non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Detection of extrathoracic metastases by positron emission tomography in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Staging non-small cell lung cancer with whole-body PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Significance of metastatic disease in subaortic lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. The Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900302-7

7 January 2021

10.1016/S0169-5002(03)00302-7

Identifiers

DOI

1 reference

9 August 2017

1 reference